Kimberly-Clark completes acquisition of Kenvue

Kimberly-Clark (NASDAQ: KMB) said it has completed its acquisition of Kenvue, combining the two consumer health and personal care companies. The combined portfolio includes 10 billion-dollar brands, among them Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex and Scott.

Kenvue shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each Kenvue share. Kenvue stock stopped trading on the New York Stock Exchange at the market open on November 2, 2026. Kimberly-Clark reaffirmed anticipated run-rate synergies of about $2.1 billion, including roughly $1.9 billion in cost synergies over three years after close.

Kimberly-Clark will operate four segments: North America, Asia Pacific Focus Markets, Europe, Middle East and Africa, and Enterprise Markets. Three Kenvue directors joined Kimberly-Clark's board, which now has 13 members, and three Kimberly-Clark directors stepped down at closing.